Urologische Klinik

The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer (2015) Wach S, Al-Janabi O, Weigelt K, Fischer K, Greither T, Marcou M, Theil G, et al. Journal article SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer (2015) Eichelberg C, Vervenne WL, De Santis M, Von Weikersthal LF, Goebell P, Lerchenmueller C, Zimmermann U, et al. Journal article Molecular Concepts of Immunomodulation for the Treatment of Metastatic Renal Cell Carcinomas: Where are We Now? (2015) Goebell P, Bedke J Journal article, Editorial Urotechnology: a new interdisciplinary platform for promoting and managing of technical innovations in urology (2015) Miernik A, Becker C, Wullich B, Schoenthaler M, Arnolds BJ, Wetterauer U Journal article miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis (2015) Benderska N, Dittrich AL, Knaup S, Rau T, Neufert C, Wach S, Fahlbusch FB, et al. Journal article The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence (2015) Karl A, Buchner A, Tympner C, Kirchner T, Ganswindt U, Belka C, Ganzer R, et al. Journal article The new semisynthetic cardenolide analog 3β-[2-(1-amantadine)-1-on-ethylamine]-digitoxigenin (AMANTADIG) efficiently suppresses cell growth in human leukemia and urologic tumor cell lines (2015) Nolte E, Sobel A, Wach S, Hertlein H, Ebert N, Müller-Uri F, Slany R, et al. Journal article, Original article Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma (2015) Jasinski-Bergner S, Stoehr C, Bukur J, Massa C, Braun J, Huettelmaier S, Spath V, et al. Journal article Non-steroidal antiandrogen monotherapy compared with luteinizing hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: a Cochrane systematic review (2015) Kunath F, Grobe HR, Ruecker G, Motschall E, Antes G, Dahm P, Wullich B, Meerpohl JJ Journal article Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011 (2015) Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Stabenow R, et al. Journal article